Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease marketIonis' lipid-lowering drug hits phase 3 goal, teeing up filings - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on September 26, 2023 at 11:00 AM in business No comments 10